Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma
Katharina Pachmann, O. Camara, T. Kroll, M. Gajda, A. K. Gellner, J. Wotschadlo, I. B. RunnebaumVolume:
137
Language:
english
Pages:
11
DOI:
10.1007/s00432-011-1000-6
Date:
September, 2011
File:
PDF, 486 KB
english, 2011